For close to two decades Purdue has engaged in many initiatives to stem prescription opioid abuse.

Click on the boxes below to see our collaborative efforts with states, communities, industry partners and law enforcement.

All opioids, including those with abuse-deterrent properties, expose users to the risks of addiction, abuse, and misuse which can lead to overdose and death.

Purdue developed the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) system…

LEARN MORE

Purdue developed the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) system to detect and study abuse, misuse, and diversion on a nationwide basis. Purdue transferred ownership of RADARS in 2006 to not-for-profit Denver Health and Hospital Authority’s Rocky Mountain Poison and Drug Center. Purdue transferred the system to an independent third party which allowed pharmaceutical companies and government agencies to more readily access valuable data on opioid abuse and diversion.

Purdue developed and deployed Radio Frequency ID technology to track medication bottles…

LEARN MORE

Purdue developed and deployed Radio Frequency ID technology to track medication bottles and protect against counterfeiting and diversion.

Purdue developed and deployed a bottle tracking program…

LEARN MORE

Purdue developed and deployed a bottle tracking program to address theft of medication from pharmacies, with more than 500 devices employed in more than 30 states, leading to over 190 arrests and clearance of more than 200 robberies.

Purdue supported the National Sheriffs’ Association’s (NSA) “Saving Lives” program…

LEARN MORE

Purdue supported the National Sheriffs’ Association’s (NSA) “Saving Lives” program with funding of approximately $850,000 for training on use of and distribution of naloxone overdose kits, with nearly 3,500 doses to 21 states.

Purdue provided a $3.1 million grant to form a public-private partnership with the Commonwealth of Virginia…

LEARN MORE

Purdue provided a $3.1 million grant to form a public-private partnership with the Commonwealth of Virginia to enhance its PDMP and the use of data within electronic health records.

Purdue has been working with Geisinger Health System […] on a study of interdisciplinary pain treatment…

LEARN MORE

Since 2016, Purdue has been working with Geisinger Health System in Danville, Pa. on a study of interdisciplinary pain treatment involving wearable technology, spending approximately $1.2 million.

Purdue partnered with North Carolina organizations Project Lazarus…

LEARN MORE

Purdue partnered with North Carolina organizations Project Lazarus – a non-profit providing training and technical assistance to communities and clinicians addressing prescription medication issues – and Safe Kids North Carolina to support state-wide medicine disposal activities and conduct research to evaluate the impact of community-based prevention programs on opioid-related overdoses, abuse, and diversion, spending approximately $600,000.

Purdue became a proud member of the Prescription Drug Safety Network…

LEARN MORE

In 2017, Purdue became a proud member of the Prescription Drug Safety Network, supporting efforts to bring prevention education created by EVERFI to high school students across the U.S. Purdue subsidiaries Adlon Therapeutics and Rhodes Pharma/Rhodes Tech joined the Network in 2019. To date, 60,000 students have accessed EVERFI’s course in our sponsored regions.

Purdue supported NADDI with $1.77 million grant to launch National PDMP Enhanced Data Exchange (NPEDE)…

LEARN MORE

Purdue supported NADDI with $1.77 million grant to launch National PDMP Enhanced Data Exchange (NPEDE) in four to five pilot states in conjunction with data and analytics solutions provider Appriss.

Purdue began accelerating the development of an opioid overdose reversal agent…

LEARN MORE

Purdue began accelerating the development of an opioid overdose reversal agent, committing to spend approximately $10+ million on research between 2018 and 2020. In 2019, Purdue enrolled the first participant to a clinical study to examine the pharmacokinetic properties of nalmefene hydrochloride. The U.S. Food and Drug Administration has granted Fast Track and Competitive Generic Therapy designations for nalmefene.

Purdue provided grants to Harm Reduction Therapeutics…

LEARN MORE

Purdue provided a $3.42 million grant to Harm Reduction Therapeutics to advance the development of its low-cost, over-the-counter naloxone nasal spray. Purdue announced in June 2020 that it will provide up to $6.5 million of additional financial support.

Purdue has spent approximately $1 billion to develop opioids with abuse-deterrent properties.

LEARN MORE

Purdue has spent approximately $1 billion to develop opioids with abuse-deterrent properties.

Purdue has frequently conducted and supported discovery research to develop non-opioid pain medications…

LEARN MORE

Purdue has frequently conducted and supported discovery research to develop non-opioid pain medications, spending approximately $400 million from 2000-2014. In January 2019, Purdue forged a partnership with Alivio Therapeutics to leverage the company’s inflammation-targeting technology to develop a non-opioid pain treatment.

Purdue provided more than $4 million to develop “Painfully Obvious,” a prescription drug abuse awareness program…

LEARN MORE

Purdue provided more than $4 million to develop “Painfully Obvious,” a prescription drug abuse awareness program for pre-teens, parents, and middle school teachers.

Purdue developed RxPATROL (Pattern Analysis Tracking Robberies and Other Losses)…

LEARN MORE

Purdue developed RxPATROL (Pattern Analysis Tracking Robberies and Other Losses), the first national database that tracks, analyzes, and provides information on pharmacy crime to law enforcement and retail pharmacies. Purdue continues to maintain this database today.

Purdue provided funding of approximately $2.7 million to support the Partnership for Drug-Free America…

LEARN MORE

Beginning in 2004 extending through 2016, Purdue provided funding of approximately $2.7 million to support the Partnership for Drug-Free America (later named Drug-Free Kids). Purdue’s contribution supported prevention education, a toll-free parent hotline in both Spanish and English, and “Time to Act,” a community education program and website for parents, guiding them in step-by-step action if they think or know their child is using drugs or drinking alcohol.

Purdue spent over $1.35 million to create […] “Communities That Care”

LEARN MORE

Purdue spent over $1.35 million to create a community partnership program called “Communities That Care,” for prevention outreach on controlled substances issues in 21 communities.

Purdue supported the National Association of Drug Diversion Investigators (NADDI)…

LEARN MORE

Beginning in 2008 through 2017, Purdue supported the National Association of Drug Diversion Investigators (NADDI) with grants totaling approximately $2.8 million to provide law enforcement with resources to help combat prescription drug abuse and diversion.

Purdue provided a $1 million grant to the National Association of Boards of Pharmacy (NABP) to help launch its InterConnect hub…

LEARN MORE

Purdue provided a $1 million grant to the National Association of Boards of Pharmacy (NABP) to help launch its InterConnect hub, which is designed to enable healthcare professionals to track prescriptions for monitored drugs in other states and help detect “doctor shopping” across state lines, while also protecting patients’ privacy.

Purdue shared the CDC Guideline for Prescribing Opioids for Chronic Pain with over 140,000 healthcare providers…

LEARN MORE

Purdue shared the U.S. Centers for Disease Control and Prevention (CDC) Guideline for Prescribing Opioids for Chronic Pain with over 140,000 healthcare providers to promote appropriate prescribing and use.

Purdue supported the pregnancy recovery pilot program…

LEARN MORE

Purdue has supported the Parent Partnership Unit at The University of Pittsburgh Medical Center’s Magee-Womens Hospital with $325,000 in grants over two years.

Purdue supported Ironton/Lawrence County Ohio’s Pay for Success (Recovery to Workforce) Model…

LEARN MORE

Purdue supported Ironton/Lawrence County Ohio’s Pay for Success (Recovery to Workforce) Model with a grant of approximately $1.5 million over three years. Forty individuals with substance use disorder completed this award-winning program.

Purdue gave $1 million to the Substance Use Disorder Residential Services Treatment Facility in Indiana…

LEARN MORE

Purdue gave $1 million to the Substance Use Disorder Residential Services Treatment Facility in Indiana.

Purdue supported Domus Kids – a nonprofit supporting struggling students in the Stamford, Conn. area…

LEARN MORE

Purdue has supported Domus Kids – a nonprofit supporting struggling students in the Stamford, Conn. area – with grants, in-kind and monetary donations including refurbished i-pads, school supplies and holiday gifts.

Purdue supported the Opioid Response Innovation Initiative…

LEARN MORE

Purdue has provided the Opioid Response Innovation Initiative with more than $375,000 in grants to support grassroots education, harm reduction and recovery efforts in Arizona, West Virginia, Tennessee and Kentucky.

Purdue supported Trek Medics…

LEARN MORE

Purdue provided Trek Medics with a $200,000 grant to bring its Beacon technology to help deliver naloxone to communities across the U.S. As of July 2020, Trek Medics’ estimates the program saved 60 lives in 30 days in Hartford, Ct.

Purdue funded youth-focused recovery outreach and community teams in Hamden, Conn. …

LEARN MORE

Purdue provided multi-year funding for a youth recovery program at The Children’s Center of Hamden in Connecticut. To date, the program has connected with 91 teens, with 27 participating in programming and 21 receiving treatment support and services.

Purdue provided grants to Harm Reduction Therapeutics…

LEARN MORE

Purdue provided a $3.42 million grant to Harm Reduction Therapeutics to advance the development of its low-cost, over-the-counter naloxone nasal spray. Purdue announced in June 2020 that it will provide up to $6.5 million of additional financial support.

Purdue supported New York’s “Keep It Moving”…

LEARN MORE

Purdue provided financial support and in-kind donations to New York’s “Keep It Moving” to conduct naloxone education and training programs.

Purdue supported Providence General Foundation to help those impacted by opioids…

LEARN MORE

Purdue provided a grant to Providence General Foundation for a two-part program called “Hope and Healing for Those Impacted by Opioids.” Through the grant, Providence Regional Medical Center Everett (Washington) initiated an observational clinical study and established a Behavioral Health Urgent Care.

Purdue supported Generations United with a $100,000 grant to provide prevention information and education to grandfamilies…

LEARN MORE

Purdue supported Generations United with a $100,000 grant to provide prevention information and education to grandfamilies affected by opioid and substance abuse.

Purdue provided support to Marshall University to research a translational model for neonatal abstinence syndrome.

LEARN MORE

Purdue provided support to Marshall University to research a translational model for neonatal abstinence syndrome.

Purdue supported recovery community programs in rural Indiana…

LEARN MORE

Purdue provided a $295,000 grant to Margaret Mary Health, a rural critical access hospital in Indiana, to support its recovery community programs.

Purdue gave a grant to Voices of Hope…

LEARN MORE

Purdue provided a $75,000 grant to Maryland-based Voices of Hope to support a youth peer recovery program.

Purdue provided grants to the “Ready to Work” program at Pacific House, a men’s shelter in Stamford, Conn.

LEARN MORE

Purdue provided grants to the “Ready to Work” program at Pacific House, a men’s shelter in Stamford, Conn.

Purdue supported the Governor’s Prevention Partnership in Connecticut with over $700,000 in grants…

LEARN MORE

Since 2005, Purdue has supported the Connecticut-based Governor’s Prevention Partnership’s efforts to prevent substance abuse, underage drinking, and violence among youth. Total grants exceed $700,000.

Purdue provided a $600,000 grant for Tennessee’s Renewal House…

LEARN MORE

Purdue has provided $600,000 in grant funding to support for Tennessee’s Renewal House’s Career Renewal program. To date, 69 women have completed the program.

Purdue supported Domus Kids – a nonprofit supporting struggling students in the Stamford, Conn. area…

LEARN MORE

Purdue has supported Domus Kids – a nonprofit supporting struggling students in the Stamford, Conn. area – with grants, in-kind and monetary donations including refurbished i-pads, school supplies and holiday gifts.

Purdue provided grants to the City University of New York’s Research Foundation…

LEARN MORE

Purdue has provided $100,000 in grants to the City University of New York’s Research Foundation for the “Workforce Development and Continuing Education Recovery Peers Internship Fund” initiative in the Bronx, N.Y.

Purdue uses comprehensive anti-diversion safety and surveillance processes to track shipments from manufacturing plants.

LEARN MORE

Purdue uses comprehensive anti-diversion safety and surveillance processes to track shipments from manufacturing plants.

Purdue has provided approximately 1.2 million placebo tablets to over 1,000 law enforcement agencies since 2004.

LEARN MORE

Purdue has provided approximately 1.2 million placebo tablets to over 1,000 law enforcement agencies since 2004.

Purdue began a program to provide tamper-resistant prescription pads at no cost to healthcare professionals…

LEARN MORE

Purdue began a program to provide tamper-resistant prescription pads at no cost to healthcare professionals. These prescription pads were ordered by more than 16,000 Drug Enforcement Administration (DEA)-registered healthcare professionals.

Purdue voluntarily developed a RiskMAP…

LEARN MORE

Purdue voluntarily developed a risk management plan (RiskMAP) in coordination with the FDA to help detect and prevent opioid abuse and diversion.

Purdue worked with The Governor’s Prevention Partnership in Connecticut on substance abuse education…

LEARN MORE

Purdue worked with The Governor’s Prevention Partnership in Connecticut on substance abuse education, including radio and TV public service announcements. Purdue dedicated more than $550,000 to this effort.

Purdue developed and distributed an education campaign […] about safe medication storage and disposal.

LEARN MORE

Purdue developed and distributed an educational campaign on radio, TV, and print media, titled “Empty the Medicine Cabinet,” about safe medication storage and disposal.

Purdue distributed more than 47,000 prescription medication identification cards […] to law enforcement officers…

LEARN MORE

Purdue distributed more than 47,000 prescription medication identification cards created by the National Association of Drug Diversion Investigators (NADDI) to law enforcement officers in 210 agencies in 40 states. These cards were created to assist law enforcement in identifying tablets seized during arrests.

Purdue worked with partners to develop the Controlled Substances Patterns of Utilization Requiring Evaluation (CS PURE)…

LEARN MORE

Purdue worked with the University of Minnesota and Clinical Pharmacology Services to develop the Controlled Substances Patterns of Utilization Requiring Evaluation (CS PURE) program for managed care companies to evaluate data.

Purdue supported states that were considering adopting Prescription Drug Monitoring Programs (PDMPs).

LEARN MORE

Purdue supported states that were considering adopting Prescription Drug Monitoring Programs (PDMPs).

Crime Stoppers USA and Purdue partnered to publicize descriptions of suspects involved in the illegal diversion of prescription medication…

LEARN MORE

Crime Stoppers USA and Purdue partnered to publicize descriptions of suspects involved in the illegal diversion of prescription medication. Purdue also contributed funding to support financial awards in exchange for information to help solve pharmacy-related crimes.

Purdue supported the National Community Pharmacists Association’s (NCPA)…

LEARN MORE

Purdue supported the National Community Pharmacists Association’s (NCPA) efforts to educate pharmacists and staff about preventing pharmacy crime through grants totaling over $65,000.

Purdue began supporting Community Anti-Drug Coalitions of America (CADCA) programs…

LEARN MORE

Purdue began supporting Community Anti-Drug Coalitions of America (CADCA) programs to help community groups combat prescription drug abuse.

Purdue provided funding to support the U.S. Conference of Mayors’ prescription drug abuse awareness campaign.

LEARN MORE

Purdue provided funding to support the U.S. Conference of Mayors’ prescription drug abuse awareness campaign.

Purdue provided $90,000 to support the NCPA’s Prescription Drug Safety Awards.

LEARN MORE

Between 2009 – 2014, Purdue provided $90,000 to support the NCPA’s Prescription Drug Safety Awards.

Purdue launched the SafeguardMyMeds​.org website and a public service campaign…

LEARN MORE

Working with the NCPA, Purdue launched the SafeguardMyMeds​.org website and a public service campaign to provide information about safeguarding prescription medicines.

Purdue supported the National Council on Patient Information and Education and the Substance Abuse and Mental Health Services Administration (SAMHSA) with grants…

LEARN MORE

Between 2010–2015, Purdue supported the National Council on Patient Information and Education and the Substance Abuse and Mental Health Services Administration (SAMHSA) with grants totaling approximately $271,000 to help prevent teen prescription drug abuse, including programs to train parents, educators, healthcare professionals, and other “Teen Influencers.”

Purdue developed RxSafetyMatters​.org…

LEARN MORE

Purdue developed RxSafetyMatters​.org to provide healthcare professionals, families, and law enforcement with information about curbing abuse and diversion.

Purdue supported Northeast Communities Against Substance Abuse, Inc…

LEARN MORE

Purdue supported Northeast Communities Against Substance Abuse, Inc., with grants totaling $184,000 in connection with its Teen Influencers program and its local media campaign.

Purdue provided the U.S. Conference of Mayors with a $225,000 grant…

LEARN MORE

Purdue provided the U.S. Conference of Mayors with a $225,000 grant to fund its “Safeguard My Meds Prescription Drug Abuse Prevention Recognition Program.” This program awards cities with outstanding local initiatives that have the greatest potential to reduce the misuse and abuse of prescription drugs, particularly among young people.

Purdue partnered with the National Education Association Health Information Network and provided grants totaling approximately $500,000…

LEARN MORE

Purdue partnered with the National Education Association Health Information Network and provided grants totaling approximately $500,000 to create a resource guide for high school teachers, titled “Rx for Understanding: Preventing Prescription Drug Abuse.”

Purdue delivered the U.S. Surgeon General’s “TurnTheTideRx” materials to prescribers…

LEARN MORE

Beginning in 2016, Purdue delivered the U.S. Surgeon General’s “TurnTheTideRx” materials to prescribers. These materials outline considerations for healthcare professionals when prescribing opioids for chronic pain.

Purdue shared CDC Tear Sheets with prescribers…

LEARN MORE

Starting in 2016, Purdue shared CDC Tear Sheets on “Prescription Opioids: What You Need to Know” and “Risk of Addiction, Abuse, & Misuse of Opioids” with prescribers.

Purdue provided a $3.1 million grant to form a public-private partnership with the Commonwealth of Virginia…

LEARN MORE

Purdue provided a $3.1 million grant to form a public-private partnership with the Commonwealth of Virginia to enhance its PDMP and the use of data within electronic health records.

Purdue entered into a two-year collaborative research partnership with the University of Oklahoma…

LEARN MORE

In 2016, Purdue entered into a two-year collaborative research partnership with the University of Oklahoma in connection with a fellowship to study prescription drug use and overdose deaths in the Medicaid population, with funding of more than $215,000.

In partnership with University of Nebraska, Purdue supported scholarships…

LEARN MORE

In partnership with University of Nebraska, Purdue supported scholarships totaling approximately $254,000 over three years for nine students in the area of pain research.

Purdue has collaborated with the NIH and NIDA on a public-private partnership as part of the “Helping to End Addiction Long-term” (HEAL) initiative…

LEARN MORE

Since 2017, Purdue has collaborated with the National Institutes of Health (NIH) and the National Institute on Drug Abuse (NIDA) on a public-private partnership as part of the “Helping to End Addiction Long-term” (HEAL) initiative to advance treatments for opioid use disorder and non-opioid, non-addictive pain medications.

Purdue supported the Connecticut Prevention Network with a $400,000 grant…

LEARN MORE

Purdue supported the Connecticut Prevention Network (CPN) with a $400,000 grant for parent and student prescription drug abuse prevention efforts. Through this grant, CPN delivered EVERFI’s Prescription Drug Safety course to 79 new community-based organizations.

Purdue supported organizations during COVID-19

LEARN MORE

Purdue has provided $500,000 in monetary support to local and national organizations focused on the pandemic, as well as those delivering harm reduction programs, improving access to medication-assisted treatment, and supporting continuity of recovery services during the pandemic.

Purdue supported Whittier Street Health Center…

LEARN MORE

Purdue provided a $50,000 grant to Whittier Street Health Center in Boston to support the expansion of their mobile naloxone distribution program.